G2/M perturbations with paclitaxel and radiation cause cytotoxicity in HepG2 hepatocellular carcinoma cells: Implications for developing therapies

G. R. Gorla, S. Slehria, A. N. Irani, B. Vikram, Sanjeev Gupta

Research output: Contribution to journalArticle

Abstract

We used a cell line model to analyze whether G2/M perturbations could cause cytotoxicity in hepatocellular carcinoma (HCC). Studies were conducted with paclitaxel and radiation. Cell viability assays showed that the IC50 of paclitaxel was 19 nM. This IC50 of paclitaxel decreased to 6 nM when HepG2 cells were treated with radiation. Flow cytometry showed that cells accumulated in G2/M following paclitaxel and radiation treatment, with >50% in G2/M following treatment with paclitaxel and radiation in combination. Exposure to paclitaxel and radiation increased apoptosis rates in HepG2 cells, although nonapoptotic cell death was more frequent. The colony-forming ability of HepG2 cells decreased in vitro after treatment with paclitaxel and radiation. Similarly, tumor-forming ability of HepG2 cells was decreased in immunodeficient animals treated with paclitaxel. These findings indicate that analysis of mechanisms inducing G2/M lesions will be helpful for developing treatments for HCC.

Original languageEnglish (US)
Pages (from-to)229-238
Number of pages10
JournalPathogenesis
Volume1
Issue number4
StatePublished - 2000

Fingerprint

Paclitaxel
Hepatocellular Carcinoma
Radiation
Hep G2 Cells
Therapeutics
Inhibitory Concentration 50
Cell Survival
Flow Cytometry
Cell Death
Apoptosis
Cell Line
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

G2/M perturbations with paclitaxel and radiation cause cytotoxicity in HepG2 hepatocellular carcinoma cells : Implications for developing therapies. / Gorla, G. R.; Slehria, S.; Irani, A. N.; Vikram, B.; Gupta, Sanjeev.

In: Pathogenesis, Vol. 1, No. 4, 2000, p. 229-238.

Research output: Contribution to journalArticle

@article{81a41de63acf45a3a544a618864e8cf5,
title = "G2/M perturbations with paclitaxel and radiation cause cytotoxicity in HepG2 hepatocellular carcinoma cells: Implications for developing therapies",
abstract = "We used a cell line model to analyze whether G2/M perturbations could cause cytotoxicity in hepatocellular carcinoma (HCC). Studies were conducted with paclitaxel and radiation. Cell viability assays showed that the IC50 of paclitaxel was 19 nM. This IC50 of paclitaxel decreased to 6 nM when HepG2 cells were treated with radiation. Flow cytometry showed that cells accumulated in G2/M following paclitaxel and radiation treatment, with >50{\%} in G2/M following treatment with paclitaxel and radiation in combination. Exposure to paclitaxel and radiation increased apoptosis rates in HepG2 cells, although nonapoptotic cell death was more frequent. The colony-forming ability of HepG2 cells decreased in vitro after treatment with paclitaxel and radiation. Similarly, tumor-forming ability of HepG2 cells was decreased in immunodeficient animals treated with paclitaxel. These findings indicate that analysis of mechanisms inducing G2/M lesions will be helpful for developing treatments for HCC.",
author = "Gorla, {G. R.} and S. Slehria and Irani, {A. N.} and B. Vikram and Sanjeev Gupta",
year = "2000",
language = "English (US)",
volume = "1",
pages = "229--238",
journal = "Pathogenesis",
issn = "1024-5359",
publisher = "Overseas Production",
number = "4",

}

TY - JOUR

T1 - G2/M perturbations with paclitaxel and radiation cause cytotoxicity in HepG2 hepatocellular carcinoma cells

T2 - Implications for developing therapies

AU - Gorla, G. R.

AU - Slehria, S.

AU - Irani, A. N.

AU - Vikram, B.

AU - Gupta, Sanjeev

PY - 2000

Y1 - 2000

N2 - We used a cell line model to analyze whether G2/M perturbations could cause cytotoxicity in hepatocellular carcinoma (HCC). Studies were conducted with paclitaxel and radiation. Cell viability assays showed that the IC50 of paclitaxel was 19 nM. This IC50 of paclitaxel decreased to 6 nM when HepG2 cells were treated with radiation. Flow cytometry showed that cells accumulated in G2/M following paclitaxel and radiation treatment, with >50% in G2/M following treatment with paclitaxel and radiation in combination. Exposure to paclitaxel and radiation increased apoptosis rates in HepG2 cells, although nonapoptotic cell death was more frequent. The colony-forming ability of HepG2 cells decreased in vitro after treatment with paclitaxel and radiation. Similarly, tumor-forming ability of HepG2 cells was decreased in immunodeficient animals treated with paclitaxel. These findings indicate that analysis of mechanisms inducing G2/M lesions will be helpful for developing treatments for HCC.

AB - We used a cell line model to analyze whether G2/M perturbations could cause cytotoxicity in hepatocellular carcinoma (HCC). Studies were conducted with paclitaxel and radiation. Cell viability assays showed that the IC50 of paclitaxel was 19 nM. This IC50 of paclitaxel decreased to 6 nM when HepG2 cells were treated with radiation. Flow cytometry showed that cells accumulated in G2/M following paclitaxel and radiation treatment, with >50% in G2/M following treatment with paclitaxel and radiation in combination. Exposure to paclitaxel and radiation increased apoptosis rates in HepG2 cells, although nonapoptotic cell death was more frequent. The colony-forming ability of HepG2 cells decreased in vitro after treatment with paclitaxel and radiation. Similarly, tumor-forming ability of HepG2 cells was decreased in immunodeficient animals treated with paclitaxel. These findings indicate that analysis of mechanisms inducing G2/M lesions will be helpful for developing treatments for HCC.

UR - http://www.scopus.com/inward/record.url?scp=0034084606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034084606&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034084606

VL - 1

SP - 229

EP - 238

JO - Pathogenesis

JF - Pathogenesis

SN - 1024-5359

IS - 4

ER -